- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
AppliedVR Provides Veterans Alternative CLBP Treatment
RelieVRx enables Veterans a non-pharmacological, noninvasive treatment option.
AppliedVR, an immersive therapeutics (ITx) company that provides a virtual-reality approach to medicine, announced a contract with the U.S. Department of Veterans Affairs (VA) to provide its FDA-authorized RelieVRX solution to select Veterans impacted by chronic lower back pain (CLBP).
The Veterans Health Administration (VHA) provides care to more than 9 million Veterans, making it the largest integrated healthcare system in the U.S. Further, more than 50% of Veterans who receive care at VHA facilities are affected by chronic pain. The contract calls for healthcare providers at 18 VHA locations to be able to prescribe the FDA-authorized RelieVRx program to Veterans for use in their homes.
The program enables Veterans access to non-pharmacological, noninvasive treatment options like virtual reality. RelieVRx is indicated as an adjunctive treatment for CLBP and its eight-week program has been clinically demonstrated to decrease pain severity and pain interference in the lives of people experiencing CLBP.
Read more about the RelieVRx and VA program.
Trial Launches to Explore Using Virtual Reality to Treat Shortsightedness in Children
July 27th 2023A new trial will determine the effectiveness of using virtual reality to treat myopia in children. The treatment combines the use of a VR headset with a phone app that is designed to stimulate dopamine releases in the retina.
